WO2002076405A3 - Compositions and methods of treatment of ulcerating diseases, burns, and related conditions - Google Patents

Compositions and methods of treatment of ulcerating diseases, burns, and related conditions Download PDF

Info

Publication number
WO2002076405A3
WO2002076405A3 PCT/US2002/009527 US0209527W WO02076405A3 WO 2002076405 A3 WO2002076405 A3 WO 2002076405A3 US 0209527 W US0209527 W US 0209527W WO 02076405 A3 WO02076405 A3 WO 02076405A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
burns
treatment
related conditions
compositions
Prior art date
Application number
PCT/US2002/009527
Other languages
French (fr)
Other versions
WO2002076405A2 (en
Inventor
Jack L Arbiser
Original Assignee
Univ Emory
Jack L Arbiser
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory, Jack L Arbiser filed Critical Univ Emory
Priority to AU2002306924A priority Critical patent/AU2002306924A1/en
Priority to US10/473,171 priority patent/US20040097587A1/en
Publication of WO2002076405A2 publication Critical patent/WO2002076405A2/en
Publication of WO2002076405A3 publication Critical patent/WO2002076405A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Abstract

Pharmaceutical compositions and methods of treating ulcerating diseases, burns, and related conditions are disclosed. The methods include administering to a host in need of treatment an effective amount of at least one retinoid receptor compound. In addition, the pharmaceutical compositions include at least one retinoid receptor compound in combination with a pharmaceutically acceptable carrier. The retinoid receptor compound can be present in a dosage level effective to treat conditions listed above.
PCT/US2002/009527 2001-03-27 2002-03-27 Compositions and methods of treatment of ulcerating diseases, burns, and related conditions WO2002076405A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002306924A AU2002306924A1 (en) 2001-03-27 2002-03-27 Compositions and methods of treatment of ulcerating diseases, burns, and related conditions
US10/473,171 US20040097587A1 (en) 2002-03-27 2002-03-27 Compositions and methods of treatment of ulcerating diseases, burns, and related conditions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27909301P 2001-03-27 2001-03-27
US60/279,093 2001-03-27

Publications (2)

Publication Number Publication Date
WO2002076405A2 WO2002076405A2 (en) 2002-10-03
WO2002076405A3 true WO2002076405A3 (en) 2002-12-19

Family

ID=23067600

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/009527 WO2002076405A2 (en) 2001-03-27 2002-03-27 Compositions and methods of treatment of ulcerating diseases, burns, and related conditions

Country Status (2)

Country Link
AU (1) AU2002306924A1 (en)
WO (1) WO2002076405A2 (en)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BRITISH JOURNAL OF DERMATOLOGY, vol. 135, no. 5, 1996, pages 671 - 677 *
DATABASE BIOSIS [online] GLASGOW G11 6NT, UK; MORTON C.A.: "Acquired perforating dermatosis in a British dialysis population", XP002956854, accession no. STN Database accession no. 1996:576511 *
DATABASE BIOSIS [online] UNIV. MICH. MED. CENTER (ANN ARBOR, MI); BULENGO-RANSBY S.M. ET AL.: "Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients", XP002956855, accession no. STN Database accession no. 1993:370043 *
NEW ENGLAND JOURNAL OF MEDICINE, vol. 328, no. 20, 1993, pages 1438 - 1443 *

Also Published As

Publication number Publication date
WO2002076405A2 (en) 2002-10-03
AU2002306924A1 (en) 2002-10-08

Similar Documents

Publication Publication Date Title
IL267381A (en) Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
NO20014842D0 (en) Docet shaft in combination with rhuMAb HER2 for the treatment of cancer
DK1373215T3 (en) Gelanamycin derivatives suitable for the treatment of cancer
WO2004045593A3 (en) Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
MXPA04006039A (en) Methods for the treatment of peripheral neural and vascular ailments.
WO2005037323A3 (en) Use of gro to treat or prevent inflammation
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
WO2003000203A3 (en) Chlorotoxin inhibition of cell invasion, cancer metastasis, angiogenesis and tissue remodeling
JP2004537500A5 (en)
WO2004010946A3 (en) Therapeutic treatment for the metabolic syndrome and type 2 diabetes
WO2001074365A3 (en) An efficacious dosage regimen of galantamine that reduces side effects
EP1262197A3 (en) Combination treatment for sleep disorders including sleep apnea
EP1304108A3 (en) Anti-arrhythmic composition and methods of treatment
WO2005009363A3 (en) Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies
WO2002065989A3 (en) Aminoglycoside treatment for lysosomal storage diseases
WO2003051290A3 (en) Treating b-cell mediated diseases by modulating dr6 activity
WO2001008637A3 (en) Treatment of premenstrual syndrome and menopause
MD2549F1 (en) Method of treatment of the chronic viral hepatitis C
AU1656997A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer
WO2002076393A3 (en) Antiagionecic, antitumor, chemopreventative agents
WO2002076405A3 (en) Compositions and methods of treatment of ulcerating diseases, burns, and related conditions
WO2000061171A3 (en) Uses of mammalian ox2 protein and related reagents
EA199700025A1 (en) APPLICATION OF OLIGOSACCHARIDE AND ASPIRIN TO PREPARATION OF MEDICINES INTENDED FOR THE TREATMENT OF THROMBOEMBOLIC DISEASES, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10473171

Country of ref document: US

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP